Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Biopharma with personalized cell therapy raises $45M in stock sale, forges ... 

 

Biopharma with personalized cell therapy raises $45M in stock sale, forges ...
MedCity News
A company with the first FDA-approved personalized cell therapy for reducing wrinkles has raised $45 million in a private stock sale. The financing was sought to improve manufacturing capacity for the therapy and advance other uses for it such as ...
See all stories on this topic »

 

Posted on 18-Oct-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: